Causal effects of treatments for informative missing data due to progression/death

Journal of the American Statistical Association

Volumn 105, Issue 491, 2010, Pages 912-929

  Lee, Keunbaik ^a   Daniels, Michael J ^b   Sargent, Daniel J ^c  

^a LOUISIANA STATE UNIV HLTH SCI C   (United States)

^b University of Florida ^*  (United States)

^c MAYO CLINIC   (United States)

Author keywords

Ordinal data; Principal stratification; QOL; Sensitivity analysis

Indexed keywords

EID: 78649440776     PISSN: 01621459     EISSN: None     Source Type: Journal    
DOI: 10.1198/jasa.2010.ap08739     Document Type: Article

References (31)

1. Cheng, J.(2009), "Estimation and Inference for the Causal Effect of Receiving Treatment on a Multinomial Outcome," Biometrics, 65, 96-103.[912]
2. Cheng, J., and Small, D.S.(2006), "Bounds on Causal Effects in Three- Arm TrialsWith Non-Compliance," Journal of the Royal Statistical Society, Ser.B, 68, 815-836.[912]
3. Egleston, B.L., Scharfstein, D.O., Freeman, E.R., and West, S.K.(2007), "Causal Inference for Non-Mortality Outcomes in the Presence of Death," Biostatistics, 8, 526-545.[912,916]
4. Egleston, B.L., Scharfstein, D.O., and MacKenzie, E.(2009), "On Estimation of the Survivor Average Causal Effect in Observational Studies When Important Confounders Are Missing due to Death," Biometrics, 65, 497-504.[916]
5. Frangakis, C.E., and Rubin, D.B.(2002), "Principal Stratification in Causal Inference," Biometrics, 58, 21-29.[912,914]
6. Gilbert, P.B., Ronald, J.B., and Hudgens, M.G.(2003), "Sensitivity Analysis for the Assessment of Causal Vaccine Effects on Viral Load in HIV Vaccine Trials," Biometrics, 59, 531-541.[912]
7. Goldberg, R.M., Sargent, D.J.,Morton, R.F., Fuchs, C.S., Ramanathan, R.K., Williamson, S.K., Findlay, B.P., Pitot, H.C., and Albets, S.R.(2004), "A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer," Journal of Clinical Oncology, 22, 23-30.[913]
8. Harel, O., and Schafer, J.L.(2009), "Partial and Latent Ignorability in Missing- Data Problems," Biometrika, 96, 37-50.[917]
9. Hayden, D., Pauler, D.K., and Schoenfeld, D.(2005), "An Estimator for Treatment Comparisons Among Survivors in Randomized Trials," Biometrics, 61, 305-310.[912]
10. Hogan, J.W., and Laird, N.M.(1997), "Mixture Models for the Joint Distribution of Repeated Measures and Event Times," Statistics in Medicine, 16, 239-257.[912]
11. Holland, P.(1986), "Statistics and Causal Inference," Journal of the American Statistical Association, 81, 945-961.[912]
12. Imai, K.(2008), "Sharp Bounds on the Causal Effects in Randomized Experiments With Truncation-by-Death," Statistics and Probability Letters, 78, 144-149.[912]
13. Jin, H., and Rubin, D.(2008), "Principal Stratification for Causal Inference With Extended Partial Compliance," Journal of the American Statistical Association, 103, 101-110.[912]
14. Kurland, B.F., and Heagerty, P.J.(2005), "Directly Parameterized Regression Conditioning on Being Alive: Analysis of Longitudinal Data Truncated by Deaths," Biostatistics, 6, 241-258.[912]
15. Lee, K., and Daniels, M.(2007), "A Class of Markov Models for Longitudinal Ordinal Data," Biometrics, 63, 1060-1067.[912,913,917]
16. -, (2008), "Marginalized Models for Longitudinal Ordinal Data With Application to Quality of Life Studies," Statistics in Medicine, 27, 4359- 4380.[912,916]
17. McLeod, H.L., Sargent, D.J., Marsh, S., Fuchs, C., Ramanathan, R.K., Williamson, S., Findlay, B., Thibodeau, S., Petersen, G., and Goldberg, R.(2003), "Pharmacogenetic Analysis of Systemic Toxicity and Response After 5-Fluorouracil (5FU)/CPT-11, 5FU/Oxaliplatin (Oxal), or CPT-11/Oxal Therapy for Advanced Colorectal Cancer (CRC): Results From an Intergroup Trial," Proc.Am.Soc.Clin.Oncol., 22, Abstract 1013.[919]
18. Pauler, D.K., McCoy, S., and Moinpour, C.(2003), "Pattern Mixture Models for Longitudinal Quality of Life Studies in Advanced Stage Disease," Statistics in Medicine, 22, 795-809.[912]
19. Robins, J.M., Rotnitzky, A., and Zhao, L.P.(1995), "Analysis of Semiparametric Regression Models for Repeated Outcomes in the Presence of Missing Data," Journal of the American Statistical Association, 90, 106-121.[916]
20. Rotnitzky, A., Robins, J.M., and Scharfstein, D.O.(1998), "Semiparametric Regression for Repeated Outcomes With Nonignorable Nonresponse," Journal of the American Statistical Association, 93, 1321-1339.[916]
21. Roy, J., Hogan, J.W., and Marcus, B.H.(2008), "Principal Stratification With Predictors of Compliance for Randomized TrialsWith 2 Active Treatments," Biostatistics, 9, 277-289.[913,915]
22. Rubin, D.B.(1974), "Estimating Causal Effects of Treatments in Randomized and Nonrandomized Studies," Journal of Educational Psychology, 66, 688- 701.[912]
23. -, (1978), "Bayesian Inference for Causal Effects," The Annals of Statistics, 6, 34-58.[912,915]
24. -, (2000), Comment on "Causal Inference Without Counterfactuals, " by A.P.Dawid, Journal of the American Statistical Association, 6, 34-58.[912]
25. -, (2006), "Causal Inference Through Potential Outcomes and Principal Stratification: Application to Studies With 'Censoring' due to Death," Statistical Science, 21, 299-309.[912]
26. Saltz, L.B., Cox, J.V., Blanke, C., Rosen, L.S., Fehrenbacher, L., Moore, M.J., Maroun, J.A., Ackland, S.P., Locker, P.K., Pirotta, N., Elfring, G.L., Miller, L.L., for the Irinotecan Study Group (2000), "Irinotecan Plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer," New England Journal of Medicine, 343, 905-914.[913]
27. Sanoff, H.K., Sargent, D.J., Campbell, M.E., Morton, R.F., Fuchs, C.S., Ramanathan, R.K., Williamson, S.K., Findlay, B.P., Pitot, H.C., and Goldberg, R.M.(2008), "Five-Year Data and Prognostic Factor Analysis of Oxaliplatin and Irinotecan Combinations for Advanced Colorectal Cancer: N9741," Journal of Clinical Oncology, 26, 5721-5727.[919]
28. Scharfstein, D.O., Rotnitzky, A., and Robins, J.M.(1999), "Adjusting for Non- Ignorable Drop-Out Using Semiparametric Non-Response Models" (with discussion), Journal of the American Statistical Association, 94, 1096- 1146.[916]
29. Shepherd, B.E, Gilbert, P.B., and Mehrotra, D.V.(2007), "Eliciting a Counterfactual Sensitivity Parameter," The American Statistician, 61, 56-63.[918]
30. Small, D., and Tan, Z.(2008), "A Stochastic Monotonicity Assumption for the Instrumental Variables Method," working paper, University of Pennsylvania.[913]
31. Zhang, J.L., and Rubin, D.B.(2003), "Estimation of Causal Effects via Principal Stratification When Some Outcomes Are Truncated by 'Death'," Journal of Educational and Behavioral Statistics, 28, 353-368.[912]